Predictive
Oncology (NASDAQ: POAI), a company focused on applying artificial
intelligence (“AI”) to personalized medicine and drug discovery, recently
announced that its Skyline Medical Division completed the sale of 10
STREAMWAY(R) Systems to a major New York hospital (http://ibn.fm/dXHwp). An article discussing the company
reads, “For Predictive Oncology, this announcement represents a significant
financial milestone. As POAI’s largest single-hospital transaction ever, the
sale indicates the credibility and trust the STREAMWAY System is building
within the industry. In addition, the sale is another positive indication that
Skyline Medical, a POAI subsidiary, provides tremendous qualitative, long-term
potential as it continues to focus on and develop innovative and revolutionary
technology and alternatives. Through its STREAMWAY System, Skyline has achieved
sales in five of the seven continents through both direct sales and distributor
partners.”
To view the full article, visit http://ibn.fm/hnE61
About Predictive Oncology Inc.
Predictive Oncology is an AI-driven company focused on
applying artificial intelligence to personalized medicine and drug discovery.
The company applies smart tumor profiling and its AI platform to extensive
genomic and biomarker patient data sets to predict clinical outcomes and, most
importantly, improve patient outcomes for cancer patients of today and
tomorrow. Predictive Oncology currently has approximately 150,000 clinically
validated cases on its molecular information platform, with more than 38,000
specific to ovarian cancer. The company’s data is highly differentiated, having
both drug-response data and access to historical outcome data from patients.
Predictive Oncology intends to generate additional sequence data from these
tumor samples to deliver on the clear unmet market need across the
pharmaceutical industry for a multi-omic approach to new drug development. For
more information, visit the company’s website at www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates
relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
